insights_auto
Why is ORX down 2.47%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
SEK 13.40
arrow_downward
-2.47%(-0.34) 1D
Oct 2, 5:29:48 PM GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEK 14.28
High
SEK 14.28
Low
SEK 13.30
Mkt. cap
470.70M
Avg. vol.
42.95K
Volume
0.00
P/E ratio
0.57
52-wk high
SEK 43.40
52-wk low
SEK 12.20
EPS
SEK 23.61
Shares outstanding
35.13M
No. of employees
61
Open
SEK 14.28
High
SEK 14.28
Low
SEK 13.30
Mkt. cap
470.70M
Avg. vol.
42.95K
Volume
0.00
P/E ratio
0.57
52-wk high
SEK 43.40
52-wk low
SEK 12.20
EPS
SEK 23.61
Shares outstanding
35.13M
No. of employees
61
News stories
From web sources and news partners
The Lufkin Daily News
·
40 minutes ago
SpaceX's initial public offering (IPO) at the Nasdaq MarketSite in New York City
Foreign Policy Journal
·
1 hour ago
Microsoft (NASDAQ: MSFT) $678 Billion Backlog Raises Questions About Revenue Timing And Cash Conversion
Benzinga
·
40 minutes ago
Getty Images Delists From NYSE, Shares Begin Trading Over The Counter Market
24/7 Wall St.
·
7 hours ago
Why Pay to Own U.S. Stocks? This Zero-Fee ETF Is Beating the S&P 500
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB